Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-05-11 5:21 pm Sale | 13D | TIVITY HEALTH INC TVTY | Hudson Executive Capital LP | 4,795,310 9.9% | -3,960,000 (-45.23%) | View |
2020-05-06 4:19 pm Unchanged | 13D | USA TECHNOLOGIES, INC USAT | Hudson Executive Capital LP | 10,385,172 16.2% | 0 (Unchanged) | View |
2020-04-27 5:18 pm Unchanged | 13D | USA TECHNOLOGIES, INC USAT | Hudson Executive Capital LP | 10,385,172 16.2% | 0 (Unchanged) | View |
2020-03-13 4:18 pm Purchase | 13D | TIVITY HEALTH INC TVTY | Hudson Executive Capital LP | 8,755,310 18.1% | 4,377,655 (+100.00%) | View |
2020-02-24 5:26 pm Purchase | 13D | VIEWRAY INC VRAY | Hudson Executive Capital LP | 12,374,684 8.4% | 12,374,684 (New Position) | View |
2020-02-24 4:41 pm Purchase | 13D | TIVITY HEALTH INC TVTY | Hudson Executive Capital LP | 4,377,655 9.1% | 1,649,000 (+60.43%) | View |
2020-02-18 07:40 am Unchanged | 13D | USA TECHNOLOGIES, INC USAT | Hudson Executive Capital LP | 10,385,172 16.3% | 0 (Unchanged) | View |
2020-01-21 4:18 pm Unchanged | 13D | USA TECHNOLOGIES, INC USAT | Hudson Executive Capital LP | 10,385,172 16.3% | 0 (Unchanged) | View |
2020-01-16 5:05 pm Sale | 13D | EAGLE PHARMACEUTICALS INC EGRX | Hudson Executive Capital LP | 361,897 2.6% | -479,880 (-57.01%) | View |
2019-12-19 4:33 pm Purchase | 13D | TIVITY HEALTH INC TVTY | Hudson Executive Capital LP | 2,728,655 5.7% | 2,728,655 (New Position) | View |
2019-11-22 3:53 pm Unchanged | 13D | USA TECHNOLOGIES, INC USAT | Hudson Executive Capital LP | 10,385,172 16.3% | 0 (Unchanged) | View |
2019-11-18 5:02 pm Unchanged | 13D | USA TECHNOLOGIES, INC USAT | Hudson Executive Capital LP | 10,385,172 16.3% | 0 (Unchanged) | View |
2019-11-04 09:12 am Unchanged | 13D | USA TECHNOLOGIES, INC USAT | Hudson Executive Capital LP | 10,385,172 16.3% | 0 (Unchanged) | View |
2019-10-31 5:27 pm Sale | 13D | CORINDUS VASCULAR ROBOTICS, IN CVRS | Hudson Executive Capital LP | 0 0% | -30,918,454 (Position Closed) | View |
2019-10-16 5:07 pm Purchase | 13D | USA TECHNOLOGIES, INC USAT | Hudson Executive Capital LP | 10,385,172 16.3% | 245,000 (+2.42%) | View |
2019-09-27 5:00 pm Purchase | 13D | USA TECHNOLOGIES, INC USAT | Hudson Executive Capital LP | 10,140,172 16.9% | 1,944,200 (+23.72%) | View |
2019-08-05 5:17 pm Purchase | 13D | USA TECHNOLOGIES, INC USAT | Hudson Executive Capital LP | 8,195,972 13.7% | 1,000,252 (+13.90%) | View |
2019-05-20 4:07 pm Purchase | 13D | USA TECHNOLOGIES, INC USAT | Hudson Executive Capital LP | 7,195,720 12% | 7,195,720 (New Position) | View |
2019-05-14 06:29 am Sale | 13D | EAGLE PHARMACEUTICALS INC EGRX | Hudson Executive Capital LP | 841,777 6% | -108,823 (-11.45%) | View |